SNAI1 (snail homolog 1 (Drosophila)) by Schwock, J & Geddie, WR









Atlas Genet Cytogenet Oncol Haematol. 2011; 15(5)  428 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
OPEN ACCESS JOURNAL AT INIST-CNRS 
SNAI1 (snail homolog 1 (Drosophila)) 
Joerg Schwock, William R Geddie 
University of Toronto, Department of Laboratory Medicine and Pathobiology, Division of Anatomical 
Pathology, Toronto General Hospital, 200 Elizabeth Street, Room E11-219, M5G 2C4 Toronto, Ontario, 
Canada (JS, WRG) 
 
Published in Atlas Database: August 2010 
Online updated version : http://AtlasGeneticsOncology.org/Genes/SNAI1ID452ch20q13.html 
DOI: 10.4267/2042/45019 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2011 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
 
Identity 
Other names: SLUGH2, SNA, SNAH, dJ710H13.1 




Human Snail homolog 1 (SNAI1, SLUGH2, SNA, 
SNAH, dJ710H13.1), homolog of the Drosophila gene 
sna, is localized on 20q13.13 (Paznekas et al., 1999; 
Twigg and Wilkie, 1999). Both publications describe a 
SNAI1-related pseudogene SNAI1P mapped to 
chromosome 2q33-37. 
Description 
SNAI1 has 3 exons (1: 143 bp, 2: 528 bp and 3: 1015 
bp size) separated by intron 1-2 (682 bp) and intron 2-3 
(3520 bp); spanning an approximately 6 kb region. A 
CpG island has been described upstream of the coding 
sequence. 
Two silent single nucleotide polymorphisms, a T/C 
transition at position 783 and a G/A transition at 
position 1035, have been described (Twigg and Wilkie, 
1999). 
Transcription 
A single transcript of 1686 bp size gives rise to a 





Charge 13.0, isoelectric point 8.7563, molecular weight 
29082.97 Da (source: Uswest.Ensembl). 
Description 
The N-terminal portion (aa 1-150) of the Snail protein 
contains a SNAG (SNAI1/GFI) domain (aa 1-9) which 
includes the consensus sequence PRSFLV found in all
Snail family members. This motif is highly conserved 
among species and also found in several other 
transcription factors where it is associated with 
repressive functions. A serine-rich domain (SRD: aa 
90-120) and a nuclear export sequence (NES: aa 139-
148) are involved in the regulation of Snail protein 
stability and subcellular localization, respectively. 
The C-terminal portion (aa 151-264) contains 3 typical 
(154-176, 178-202, 208-230) and one atypical (236-
259) C2H2-type zinc finger (ZF) domains. 
 
Snail protein structure. 










The human SNAI1 transcript has been detected in 
placenta, adult heart and lung. Lower levels were 
reported for adult brain, liver and skeletal muscle 
(Paznekas et al., 1999). Several human fetal tissues 
were reported to express the SNAI1 transcript, with the 
highest levels detected in kidney (Twigg and Wilkie, 
1999). 
Reliable high protein expression is present in the 
extravillous trophoblast of the human placenta which 
can be utilized as positive control (Rosivatz et al.,
2006). 
 
Snail protein expression in 1st trimester human placenta. 
Method and Antibody: Schwock et al., 2010. 
Function 
Snail protein (SNAI1) is part of a superfamily of 
transcription factors composed of the SNAI and the 
SCRATCH family (Nieto, 2002; Barrallo-Gimeno and 
Nieto, 2009). The SNAI family contains two more 
members: Slug (SNAI2 (Cohen et al., 1998)) and Smuc 
(SNAI3 (Katoh, 2003)) on chromosomes 8 and 16, 
respectively. 
The Snail gene in Drosophila (sna), first identified 
during analysis of dorso-ventral patterning, is a zinc 
finger gene with repressor function required for 
mesoderm formation (Boulay et al., 1987; Leptin, 
1991). Isolation of other Snail homologues in different 
species including the human indicated a high degree of 
conservation in coding sequence and predicted protein 
pointing towards a conserved role in early 
morphogenesis (Paznekas et al., 1999). 
Snail protein functions as E-cadherin repressor and is 
essential during early developmental stages (Cano et 
al., 2000; LaBonne and Bronner-Fraser, 2000). Snail is 
re-expressed during adult life in tissue repair as well as 
in neoplasia, and, in the latter, thought to contribute to 
the acquisition of a metastatic potential in tumor cells 
(Batlle et al., 2000). The process by which Snail 
confers increased motility in individual cells is 
characterized by a down-regulation of epithelial (cell-
cell adhesion, apical-basal polarity) and up-regulation 
of mesenchymal (cell-extracellular matrix interaction, 
front-back polarity) features associated with respectiv  
changes in molecular composition of the cell which 
include (among others) cell adhesion molecules and 
intermediate filaments. This process, termed epithelial-
mesenchymal transition (EMT) (Hay, 1989; Thiery, 
2002; Peinado et al., 2007), has been classified into 3 
types: type 1 in the context of developmental processes, 
type 2 in inflammation, tissue repair and fibrosis, and 
type 3 in tumor invasion and metastasis (Kalluri and 
Weinberg, 2009). 
To exert its function as repressor, Snail nuclear import 
is mediated by importins which recognize a nuclear 
localization signal that consists of basic residues 
situated in the zinc finger region (Mingot et al., 2009). 
Inside the nucleus Snail is required to form ternary 
complexes with co-repressors via the Snag domain. 
Different ternary complexes have been described which 
consist of Ajuba as mediator for the interaction with 
PRC2 (Herranz et al., 2008), 14-3-3 and PRMT5 (Hou 
et al., 2010), Sin3A for the interaction with 
HDAC1/HDAC2 (Peinado et al., 2004), and LSD1 for 
the interaction with CoREST (Lin et al., 2010). Bindi g 
to DNA occurs via E-box elements (5'-CACCTG-3') 
found in the promoter region of different genes 
including the E-cadherin gene CDH1 (Batlle et al., 
2000; Cano et al., 2000). 
The regulation of Snail activity mainly involves the 
central part of the protein which contains most sites for 
post-translational modification: serine phosphorylation 
sites (Ser92, 96, 100, 104, 107) in the SRD as wellas 
two lysine oxidation sites (Lys98 and 137), and the
NES for Crm1-dependent nuclear export. Two 
additional serine phosphorylation sites are found N-
terminal at Ser11 and C-terminal at Ser246. 
Phosphorylation of Ser 96, 100, 104 and 107 by 
GSK3beta is associated with nuclear export, 
ubiquitination by beta-TrCP1 or FBXL14 and 
proteasomal degradation (Dominguez et al., 2003; 
Zhou et al., 2004; Vinas-Castells et al., 2010). Snail is 
positively regulated by phosphorylation of Ser11, 92 
and 246 and its protein stability is increased by 
interaction with SCP, PKA, CK2, PAK1 and LOXL2 
(Peinado et al., 2005; Yang et al., 2005; Wu et al., 
2009; MacPherson et al., 2010). 
Limited information is available on the factors directly 
controlling the SNAI1 promoter. Snail up-regulation in 
cells has been reported as a result of diverse stimuli 
including cytokines (Interleukin-6), growth factors 
(TGFbeta, FGF, PDGF, EGF) and activation of their 
corresponding receptor tyrosine kinases as well as 
activation of developmental signaling pathways such as 
Wnt and Hedgehog. Notably, TGFbeta has been 
described as important EMT trigger leading to HMGA2 
and Smad binding at the SNAI1 promoter (Thuault et 
al., 2008). Another example is Snail expression 
stimulated by HGF via the MAPK pathway and Egr-1 
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which also includes a negative feedback mechanism 
due to Snail binding at the Egr-1 promoter (Grotegu et 
al., 2006). Also, a conserved 3' enhancer element has 
been described which interacts with the SNAI1 
promoter (Palmer et al., 2007). Furthermore, Snail h s
been found to control its own expression by binding to 
an E-box in its own promoter (Peiro et al., 2006). A 
more detailed overview over the complex signaling 
pathways regulating Snail expression is given in 
several recent review publications (Peinado et al., 
2007; De Herreros et al., 2010). 
Consequences of Snail up-regulation not only include 
the repression of E-cadherin transcription, but the
negative as well as positive control of a series of genes 
involved in a range of biological functions such as cell-
cell adhesion, cell-extracellular matrix interaction, cell 
polarity, cytoskeleton, cell cycle, survival, and 
angiogenesis leading to a phenotypic shift towards 
more mesenchymal cellular characteristics (De Craene 
et al., 2005; Higashikawa et al., 2008). In the context of 
tumor-associated EMT these mesenchymal-like 
characteristics have been correlated with a greater 
resistance to different therapeutic modalities (Kajita et 
al., 2004; Kurrey et al., 2009), escape from attack by 
the immune system (Kudo-Saito et al., 2009), and 
adoption of a cancer stem cell phenotype (Mani et al., 
2008; Morel et al., 2008). 
The importance and the exact biological implications f 
Snail expression in human tumors remain a focus of 
current research (Schwock et al., 2010). Some of the 
challenges in this area may be due to the transient and 
dynamic nature of tumor-associated EMT. Also, it has 
been proposed that Snail is required as initial trigger in 
EMT, whereas maintenance of the phenotype is taken 
over by other factors potentially leaving behind a 
mesenchymal cell devoid of Snail expression (Peinado 
et al., 2007). Another intriguing recent observation s 
the presence of Snail in tumor-associated stroma and its 
impact on tumor prognosis (Franci et al., 2009). 
Homology 
Human Snail protein is 97.3, 87.2, 87.5, 57.3 and 58.4 
identical to SNAI1 in chimpanzee (Pan troglodytes), 
SNAI1 in dog (Canis lupus familiaris), Snai1 in mouse 





Involvement of Snail as a major factor in 
craniosynostosis was excluded (Paznekas et al., 1999; 
Twigg and Wilkie, 1999). Expression of SNAI1 at the 
transcript level has been detected in benign conditio s 
such as tissue fibrosis (Sato et al., 2003; Yanez-Mo et 
al., 2003; Jayachandran et al., 2009), a range of 
malignant neoplasms (Cheng et al., 2001; Rosivatz et 
al., 2002; Takeno et al., 2004), and in normal tissue 
adjacent to tumor (Pena et al., 2009). Early studies 
based on detection of the SNAI1 transcript found 
associations with lymph node metastasis (Cheng et al., 
2001; Blanco et al., 2002) and malignant effusion 
(Elloul et al., 2005) in breast cancer. A mouse model 
reported by Moody et al. (2005) implicated Snail 
expression with mammary cancer recurrence. Other 
studies described associations between elevated SNAI1 
transcript levels and hypoxia in ovarian cancer (Imai et 
al., 2003), downregulation of Vitamin D Receptor in 
colon cancer (Palmer et al., 2004; Pena et al., 2005), 
invasion and distant metastasis in oesophageal 
squamous cell carcinoma (Takeno et al., 2004), 
invasiveness (Sugimachi et al., 2003) and poor 
prognosis (Miyoshi et al., 2005) in hepatocellular 
carcinoma, and spindle cell phenotype in synovial 
sarcoma (Saito et al., 2004). However, it has been 
pointed out that transcript levels may not correlate well 
with Snail protein which is tightly regulated and subject 
to a short half-life previously reported as approximately 
25 minutes (Zhou et al., 2004). Also, transcript leve s 
may be confounded by Snail expression in the stromal 
tumor component if no micro-dissection is performed 
(Peinado et al., 2007). Immunohistochemical detection 
of Snail has been documented for a range of cancers 
including the upper gastrointestinal tract (Rosivatz e  
al., 2006; Natsugoe et al., 2007; Usami et al., 2008; 
Kim et al., 2009), head and neck (Yang et al., 2007; 
Peinado et al., 2008; Yang et al., 2008; Zidar et al., 
2008; Schwock et al., 2010), colorectum (Roy et al., 
2005; Franci et al., 2009), neuroendocrine tumors of 
the ileum (Fendrich et al., 2007), uterine cervix (Franci 
et al., 2006), endometrium (Blechschmidt et al., 2007), 
ovary (Blechschmidt et al., 2008; Jin et al., 2009; 
Tuhkanen et al., 2009), prostate (Heeboll et al., 2009), 
breast (Zhou et al., 2004), bladder (Bruyere et al., 
2009), adrenal gland (Waldmann et al., 2008), thyroid 
gland (Hardy et al., 2007), parathyroid gland (Fendrich 
et al., 2009) as well as pheochromocytoma (Waldmann 
et al., 2009) and sarcomas (Franci et al., 2006). 
Differences in immunoreactivity seem to depend on the 
individual tumor entity examined as well as technical 
issues (Schwock et al., 2010). 
Neoplasms of the gastro-intestinal tract 
Note 
Rosivatz et al. (2006) examined Snail expression in 
adenocarcinomas of the upper gastrointestinal tract. 
7.9% (27/340) of their cases were reported with 
positive staining for Snail. There was no correlation 
between Snail and E-cadherin expression or Snail and 
clinicopathological parameters. Natsugoe et al. (2007) 
examined 194 cases with oesophageal squamous cell 
carcinoma. 61.7% (84/194) were reported with positive 
staining. Snail expression was associated with deep 
invasion, increased lymph node metastasis, and 
advanced stage. No correlation was found between 
Snail and E-cadherin expression. Usami et al. (2008) 
reported a cohort of 72 cases of oesophageal squamous 






Atlas Genet Cytogenet Oncol Haematol. 2011; 15(5)  431 
cell carcinoma for which 38% (27/72) were considere 
positive. Elevated Snail expression was found at the 
invasion front, and was associated with lymphatic and
venous vessel invasion, lymph node metastasis and 
tumor stage. Furthermore, a recent study by Kim et al. 
(2009) reported Snail positivity in 42.9% (245/571) of 
gastric carcinomas where it was associated with 
invasion and lymph node metastasis. Snail staining was 
an independent indicator of prognosis by multivariate 
analysis in this study. Fendrich et al., 2007 examined 
Snail expression in neuroendocrine tumors of the 
ileum. 59% (22/37) of the primary tumors and 6 of 7 
liver metastases were reported with immunoreactivity 
for Snail. 53% (16/30) of the neuroendocrine tumors 
displayed positivity for Snail as well as Sonic 
Hedgehog. Roy et al. (2005) found a proportion of 78% 
(46/59) cases with positive staining in their study on 
colorectal cancers as well as a trend towards increased 
presence of Snail in tumors with distant metastasis. A 
more recent study on colorectal cancer by Franci et al. 
(2009) reported a similarly high proportion of 79% 
(128/162) of cases with Snail immunoreactivity. 
Interestingly, in this study a correlation between 
stromal Snail expression and decreased survival was 
found. 
Neoplasms of the head and neck 
Note 
Yang et al. (2007) reported a proportion of 37.4% 
(n=147) of primary head and neck squamous cell 
carcinomas with positive immunoreactivity for Snail. 
Snail expression was associated with lymph node 
metastasis, and co-expression with Nijmegen breakage 
syndrome 1 (NBS1) indicated short metastasis-free 
period and overall survival. Another study by Yang et 
al. (2008) reported a positive correlation between Snail 
and reduced metastasis-free and overall survival. 
Peinado et al. (2008) examined a large cohort of 
laryngeal squamous cell carcinomas for which 16% 
(40/251) were reported Snail positive including 3% 
(8/251) high-positive. They found a correlation 
between Snail and LOXL2 expression, but no 
association between Snail and disease-free or overall 
survival. Zidar et al. (2008) reported their findings on 
two cohorts of head and neck squamous cell 
carcinomas specifically distinguishing between spindle 
cell carcinomas and those of moderately differentiated 
phenotype. 19/30 of the spindle cell, but only 4/30 
cases in the moderately differentiated group were found 
to display positive immunoreactivity. There was no 
correlation between Snail and E-cadherin expression. 
Schwock et al. (2010) examined a cohort of 46 cases of 
oral squamous cell carcinoma including corresponding 
metastases. Nuclear Snail-positivity equal or in excess 
of a 5% threshold was observed in 10 tumors and 5 
metastases which corresponded to 12 cases. Individual 
Snail-positive tumor cells below this threshold, 
however, were present more frequently and found in 
primary tumors of 30 patients. Snail expression in 
tumor cells in excess of 10% was rare, but associated 
with poor outcome by univariate analysis. 
Neoplasms of the genitourinary tract 
Note 
87 primary endometrioid-type adenocarcinomas of the 
endometrium and 26 unrelated metastases were 
examined in a study by Blechschmidt et al. (2007). 
Among the primary tumors and the metastases a 
proportion of 28.7% and 53.8% were reported with 
positive Snail staining, respectively. Snail 
immunoreactivity in metastases was found to correlate 
with higher grade and reduced E-cadherin expression. 
A subsequent study by Blechschmidt et al. (2008) on 
48 primary ovarian neoplasms and 50 metastases found 
Snail immunoreactivity in 37.5% and 52%, 
respectively. A borderline significant difference in 
overall survival with Snail expression in metastases 
was noted. There was no correlation between Snail ad 
E-cadherin expression in this study. A similar study by 
Jin et al. (2009) examined 41 serous adenocarcinomas 
of the ovary with 14 matched metastases, 12 serous 
borderline tumors, 5 cystadenomas and 4 normal 
ovarian controls. There was a range of Snail 
immunoreactivity with increased nuclear positivity 
noted in the carcinoma group. Tuhkanen et al. (2009) 
compared 74 ovarian carcinomas with 24 borderline 
tumors, 21 benign ovarian neoplasms and 14 normal 
controls. Increased nuclear staining was noted with 
increasing malignancy both in the epithelial as well as 
the stromal compartment. 23% (17/74) of the ovarian 
carcinomas were reported to show focal Snail 
positivity. No association with clinicopathological 
factors was seen in this study. Heeboll et al., 2009 
examined Snail in 327 prostate cancer specimens, 15 
specimens with high-grade prostatic intraepithelial 
neoplasia (PIN), 30 specimens from patients with 
benign prostatic hyperplasia and 30 benign prostate 
tissue controls. Approximately 50% of the prostate 
cancers were found to have high Snail 
immunoreactivity compared to only 7% of the high-
grade PIN specimens. Snail expression in this study 
was associated with Gleason score, but not with 
progression or prognosis. Bruyere et al., 2009 studied 
Snail expression in transitional cell carcinoma of the 
bladder using a microarray of 87 cases. Strong Snail 
positivity was found in 43.7% and weak positivity in 
the remainder of the cases. Snail immunoreactivity in 
this study was prognostic for tumor recurrence by uni-
and multivariate analysis. 
Breast cancer 
Note 
Zhou et al. (2004) reported a study on Snail expression 
in breast cancer which found positive staining in 56% 
(72/129) of their cases; 17 with low and 55 with high 
Snail immunoreactivity. Snail correlated with GSK-
3beta inhibition and E-cadherin downregulation, and 
clinically with metastasis in this study. 










Waldmann et al. (2008) reported their findings with 
Snail expression in adrenocortical carcinomas obtained 
in a study including 26 primary tumors as well as two 
lymph node and one liver metastases. 65% (17/26) 
primary tumors showed staining for Snail with strong 
positivity found at the invasion front of 7 tumors and in 
2 of 3 metastases. Snail positivity was associated with 
advanced stage, decreased survival and higher risk for 
distant metastases. The same group reported a study on 
Snail in pheochromocytomas including 44 primary 
tumors, 3 lymph node and 2 peritoneal metastases 
(Waldmann et al., 2009). Snail positivity was reported 
for 28% (13/47) cases, and positive staining was 
associated with malignant behaviour. Hardy et al. 
(2007) published their results focused on thyroid 
neoplasms. 18/31 follicular and 28/32 papillary thyroid 
cancers as well as all of 4 lymph node metastases of 
papillary thyroid cancer were found to stain positive for 
Snail whereas normal thyroid tissue was negative. Snail 
staining was reported to be restricted to the invasive 
front and associated with a concomitant reduction in E-
cadherin reactivity. The authors of this study also 
included their findings from a Combi-TA mouse model 
showing development of papillary thyroid carcinomas. 
Fendrich et al. (2009) recently published results of a 
study focused on parathyroid neoplasms including 9 
cases of parathyroid carcinoma, 25 adenomas and 25 
cases of hyperplasia. Snail staining was positive in all 
cases of hyperplasia and 22/25 adenomas. In 
carcinomas a change in staining pattern towards the 
invasion front was noted. 
Mesenchymal neoplasms 
Note 
Franci et al. (2006) studied Snail in a series of different 
neoplasm which included sarcomas and infantile 
fibromatosis as well as epithelial neoplasms (squamous 
cell carcinoma of the uterine cervix and 
adenocarcinoma of the colon). High Snail expression 
was present in fibrosarcomas and other sarcomas. Snil 
expression in neoplasms of epithelial origin was 
restricted to the tumor-stroma interface. 
To be noted 
Note 
Mouse model. 
A CombitTA conditional mouse model of Snail 
expression has been described without morphological 
alterations, but associated with the development of both 
epithelial and mesenchymal tumors (leukemias) (Perez-
Mancera et al., 2005). Notably, suppression of the Snail 
transgene did not rescue the malignant phenotype, 
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